We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
Cap. Flow
-$18.1M
Cap. Flow %
-12.5%
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$269K
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$197K
3
MO icon
Altria Group
MO
+$144K
4
MPT
Medical Properties Trust
MPT
+$127K
5
XOM icon
ExxonMobil
XOM
+$117K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$582K
2
MPC icon
Marathon Petroleum
MPC
+$200K
3
AER icon
AerCap
AER
+$196K
4
XPO icon
XPO
XPO
+$195K
5
CPB icon
Campbell Soup
CPB
+$186K

Sector Composition

Rank Sector Weight
1 Technology 16.31%
2 Healthcare 10.05%
3 Consumer Staples 8.95%
4 Communication Services 7.78%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNQ icon
576
Vanguard Real Estate ETF
VNQ
$39B
– –
-65
Closed -$6K
VOD icon
577
Vodafone
VOD
$37.4B
– –
-3,318
Closed -$66K
VOE icon
578
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
– –
-261
Closed -$29K
VOT icon
579
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
– –
-38
Closed -$6K
VPG icon
580
Vishay Precision Group
VPG
$914M
– –
-240
Closed -$8K
VRP icon
581
Invesco Variable Rate Preferred ETF
VRP
$3.01B
– –
-1,731
Closed -$44K
VRSK icon
582
Verisk Analytics
VRSK
$25B
– –
-457
Closed -$72K
VRTX icon
583
Vertex Pharmaceuticals
VRTX
$126B
– –
-31
Closed -$5K
VSAT icon
584
Viasat
VSAT
$11.1B
– –
-39
Closed -$3K
W icon
585
Wayfair
W
$14.6B
– –
-55
Closed -$6K
WAB icon
586
Wabtec
WAB
$49.3B
– –
-11
Closed -$1K
WEC icon
587
WEC Energy
WEC
$35.1B
– –
-79
Closed -$8K
WELL icon
588
Welltower
WELL
$171B
– –
-927
Closed -$84K
WFC icon
589
Wells Fargo
WFC
$264B
– –
-1,380
Closed -$70K
WIX icon
590
WIX.com
WIX
$2.52B
– –
-36
Closed -$4K
WMB icon
591
Williams Companies
WMB
$86.1B
– –
-958
Closed -$23K
WNC icon
592
Wabash National
WNC
$527M
– –
-2,616
Closed -$38K
WOLF icon
593
Wolfspeed
WOLF
$1.71B
– –
-156
Closed -$8K
WPC icon
594
W.P. Carey
WPC
$16.4B
– –
-255
Closed -$22K
WRB icon
595
W.R. Berkley
WRB
$26.6B
– –
-1,967
Closed -$63K
WSM icon
596
Williams-Sonoma
WSM
$29.6B
– –
-60
Closed -$2K
WY icon
597
Weyerhaeuser
WY
$18.4B
– –
-1,150
Closed -$32K
X
598
DELISTED
US Steel
X
– –
-1,546
Closed -$18K
XHS icon
599
State Street SPDR S&P Health Care Services ETF
XHS
$208M
– –
-500
Closed -$31K
XLB icon
600
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
– –
-150
Closed -$4K
22 23
24
25 26

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.

  • Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
  • Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
  • Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
  • Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
  • Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
  • Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
  • Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.